The Hair Loss Encyclopedia

Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

research Induction of ornithine decarboxylase in specific subpopulations of murine epidermal cells following multiple exposures to 12-O-tetradecanoylphorbol-13-acetate, mezerein and ethyl phenylpropriolate

26 citations , January 1992 in “Carcinogenesis”

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

research SYK inhibitor entospletinib prevents ocular and skin GVHD in mice

45 citations , October 2018 in “JCI Insight”

Entospletinib effectively prevents eye and skin GVHD in mice.

research Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.

143 citations , May 2002 in “PubMed”

LGD1069 effectively prevents breast tumors in mice without toxicity.

research Ginkgolide B and bilobalide promote the growth and increase β‐catenin expression in hair follicle dermal papilla cells of American minks

12 citations , September 2019 in “BioFactors”

Ginkgolide B and bilobalide help mink hair grow by making skin cells healthier and boosting a key growth protein.

research ICP5249 Promotes Hair Growth by Activating the AMPK-Autophagy Signaling Pathway

5 citations , July 2024 in “Journal of Microbiology and Biotechnology”

ICP5249 helps hair grow by activating a specific cell pathway.

research Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson–Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies

4 citations , May 2023 in “Cells”

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

research TOPICAL IMMUNOTHERAPY IN DERMATOLOGY

22 citations , March 1999 in “International Journal of Clinical Practice”

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

research Stimulation of Hair Growth by Topical Application of FK506, a Potent Immunosuppressive Agent

54 citations , February 1994 in “Journal of Investigative Dermatology”

A Pilot Study of 2% Tofacitinib Cream with Narrowband Ultraviolet B for the Treatment of Facial Vitiligo

research A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo

25 citations , April 2019 in “Journal of The American Academy of Dermatology”

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)

research Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)

November 2025 in “SKIN The Journal of Cutaneous Medicine”

Upadacitinib effectively treats severe alopecia areata and is safe.

← Previous page